175 related articles for article (PubMed ID: 1929288)
1. Antifungal effects of the nonlinear pharmacokinetics of cilofungin, a 1,3-beta-glucan synthetase inhibitor, during continuous and intermittent intravenous infusions in treatment of experimental disseminated candidiasis.
Walsh TJ; Lee JW; Kelly P; Bacher J; Lecciones J; Thomas V; Lyman C; Coleman D; Gordee R; Pizzo PA
Antimicrob Agents Chemother; 1991 Jul; 35(7):1321-8. PubMed ID: 1929288
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of cilofungin therapy administered by continuous intravenous infusion for experimental disseminated candidiasis in rabbits.
Rouse MS; Tallan BM; Steckelberg JM; Henry NK; Wilson WR
Antimicrob Agents Chemother; 1992 Jan; 36(1):56-8. PubMed ID: 1590700
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacies of cilofungin (Ly121019) and amphotericin B against disseminated Candida albicans infection in normal and granulocytopenic mice.
Khardori N; Nguyen H; Stephens LC; Kalvakuntla L; Rosenbaum B; Bodey GP
Antimicrob Agents Chemother; 1993 Apr; 37(4):729-36. PubMed ID: 8494367
[TBL] [Abstract][Full Text] [Related]
4. Cilofungin (LY121019) shows nonlinear plasma pharmacokinetics and tissue penetration in rabbits.
Lee JW; Kelly P; Lecciones J; Coleman D; Gordee R; Pizzo PA; Walsh TJ
Antimicrob Agents Chemother; 1990 Nov; 34(11):2240-5. PubMed ID: 2073114
[TBL] [Abstract][Full Text] [Related]
5. Antifungal activity of LY303366, a novel echinocandin B, in experimental disseminated candidiasis in rabbits.
Petraitiene R; Petraitis V; Groll AH; Candelario M; Sein T; Bell A; Lyman CA; McMillian CL; Bacher J; Walsh TJ
Antimicrob Agents Chemother; 1999 Sep; 43(9):2148-55. PubMed ID: 10471556
[TBL] [Abstract][Full Text] [Related]
6. Synergy between cilofungin and amphotericin B in a murine model of candidiasis.
Hanson LH; Perlman AM; Clemons KV; Stevens DA
Antimicrob Agents Chemother; 1991 Jul; 35(7):1334-7. PubMed ID: 1929290
[TBL] [Abstract][Full Text] [Related]
7. Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits.
Petraitis V; Petraitiene R; Groll AH; Roussillon K; Hemmings M; Lyman CA; Sein T; Bacher J; Bekersky I; Walsh TJ
Antimicrob Agents Chemother; 2002 Jun; 46(6):1857-69. PubMed ID: 12019101
[TBL] [Abstract][Full Text] [Related]
8. In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin.
Bartizal K; Abruzzo G; Trainor C; Krupa D; Nollstadt K; Schmatz D; Schwartz R; Hammond M; Balkovec J; Vanmiddlesworth F
Antimicrob Agents Chemother; 1992 Aug; 36(8):1648-57. PubMed ID: 1416847
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of cilofungin (LY121019) for treatment of experimental Candida albicans endocarditis in rabbits.
Padula A; Chambers HF
Antimicrob Agents Chemother; 1989 Oct; 33(10):1822-3. PubMed ID: 2686548
[TBL] [Abstract][Full Text] [Related]
10. Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.
Petraitis V; Petraitiene R; Groll AH; Sein T; Schaufele RL; Lyman CA; Francesconi A; Bacher J; Piscitelli SC; Walsh TJ
Antimicrob Agents Chemother; 2001 Feb; 45(2):471-9. PubMed ID: 11158743
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of cilofungin and amphotericin B on experimental murine candidiasis.
Morrison CJ; Stevens DA
Antimicrob Agents Chemother; 1990 May; 34(5):746-50. PubMed ID: 2193617
[TBL] [Abstract][Full Text] [Related]
12. Intermittent Dosing of Micafungin Is Effective for Treatment of Experimental Disseminated Candidiasis in Persistently Neutropenic Rabbits.
Petraitiene R; Petraitis V; Hope WW; Walsh TJ
Clin Infect Dis; 2015 Dec; 61 Suppl 6(Suppl 6):S643-51. PubMed ID: 26567283
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma sampling.
Groll AH; Mickiene D; Petraitiene R; Petraitis V; Lyman CA; Bacher JS; Piscitelli SC; Walsh TJ
Antimicrob Agents Chemother; 2001 Oct; 45(10):2845-55. PubMed ID: 11557479
[TBL] [Abstract][Full Text] [Related]
14. Efficacy, plasma pharmacokinetics, and safety of icofungipen, an inhibitor of Candida isoleucyl-tRNA synthetase, in treatment of experimental disseminated candidiasis in persistently neutropenic rabbits.
Petraitiene R; Petraitis V; Kelaher AM; Sarafandi AA; Mickiene D; Groll AH; Sein T; Bacher J; Walsh TJ
Antimicrob Agents Chemother; 2005 May; 49(5):2084-92. PubMed ID: 15855534
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacy of cilofungin, fluconazole and amphotericin B in the treatment of systemic Candida albicans infection in the neutropenic mouse.
Bannatyne RM; Cheng PC; Fong IW
Infection; 1992; 20(3):168-70. PubMed ID: 1644494
[TBL] [Abstract][Full Text] [Related]
16. Comparative activity in vitro of cilofungin (LY 121019) with other agents used for treatment of deep-seated Candida infections.
Rennie RP; Hellman L
Mycoses; 1989 Mar; 32(3):145-50. PubMed ID: 2733726
[TBL] [Abstract][Full Text] [Related]
17. Cilofungin (LY121019), an antifungal agent with specific activity against Candida albicans and Candida tropicalis.
Hall GS; Myles C; Pratt KJ; Washington JA
Antimicrob Agents Chemother; 1988 Sep; 32(9):1331-5. PubMed ID: 3058017
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of the echinocandin caspofungin against disseminated aspergillosis and candidiasis in cyclophosphamide-induced immunosuppressed mice.
Abruzzo GK; Gill CJ; Flattery AM; Kong L; Leighton C; Smith JG; Pikounis VB; Bartizal K; Rosen H
Antimicrob Agents Chemother; 2000 Sep; 44(9):2310-8. PubMed ID: 10952573
[TBL] [Abstract][Full Text] [Related]
19. Experimental antifungal chemotherapy in granulocytopenic animal models of disseminated candidiasis: approaches to understanding investigational antifungal compounds for patients with neoplastic diseases.
Walsh TJ; Lee JW; Roilides E; Francis P; Bacher J; Lyman CA; Pizzo PA
Clin Infect Dis; 1992 Mar; 14 Suppl 1():S139-47. PubMed ID: 1562687
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a murine model of hepatic candidiasis.
Cole GT; Lynn KT; Seshan KR
J Clin Microbiol; 1990 Aug; 28(8):1828-41. PubMed ID: 2394804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
